Ranked #117 of 8,699 institutional investors
Alphabet Inc.
Mountain View, CA
$80.61B
US stock portfolio at live prices · today −$2.87B (−3.43%)
Market closed. Prices as of Nov 20, 7:41 AM ET
- Value at quarter end (Q3 2026)
- $88.35B
- Change from Q2 2026
- −$10.74B (−10.84%)
- Positions
- 29 · 4 new, 3 sold out
- Filed
- Nov 6, 2026
Holdings
Q3 2026 13F, live pricesSPCX 95.3%CME 1.32%QCOM 0.60%RVMD 0.53%PL 0.51%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SPCX Space Exploration Technologies Corp. | 555,043,560 | $76.83B | 95.3% | Added +1% |
| CME CME Group Inc. | 3,484,020 | $1.07B | 1.32% | Unchanged |
| QCOM QUALCOMM Incorporated | 2,976,982 | $482M | 0.60% | New |
| RVMD Revolution Medicines, Inc. | 2,673,909 | $426M | 0.53% | Reduced −9% |
| PL Planet Labs PBC | 35,248,893 | $410M | 0.51% | Unchanged |
| ARM Arm Holdings plc | 1,960,784 | $347M | 0.43% | Unchanged |
| ASTS AST SpaceMobile, Inc. | 8,943,486 | $229M | 0.28% | Unchanged |
| FRSH Freshworks Inc. | 14,336,643 | $176M | 0.22% | Reduced −12% |
| PBLS Parabilis Medicines, Inc. | 4,919,498 | $136M | 0.17% | Unchanged |
| TEM Tempus AI, Inc. | 1,551,102 | $92.5M | 0.11% | Unchanged |
| PATH UiPath, Inc. | 7,034,337 | $79.0M | <0.1% | Unchanged |
| PRME Prime Medicine, Inc. | 16,562,498 | $63.6M | <0.1% | Unchanged |
| MAZE Maze Therapeutics, Inc. | 1,388,583 | $45.0M | <0.1% | Unchanged |
| PAYP PayPay Corporation | 3,125,000 | $40.3M | <0.1% | Unchanged |
| LIME Neutron Holdings, Inc. | 1,898,948 | $38.3M | <0.1% | New |
| RLAY Relay Therapeutics, Inc. | 1,410,029 | $22.4M | <0.1% | Unchanged |
| FRNM Freenome, Inc. | 2,022,131 | $20.1M | <0.1% | New |
| FRVO Fervo Energy Company | 1,760,732 | $19.6M | <0.1% | Unchanged |
| LIFE Ethos Technologies Inc. | 571,907 | $18.4M | <0.1% | Reduced −84% |
| OBX Obsidian Therapeutics, Inc. | 1,224,869 | $14.9M | <0.1% | New |
| OSCR Oscar Health, Inc. | 481,988 | $12.6M | <0.1% | Unchanged |
| BEAM Beam Therapeutics Inc. | 321,604 | $6.7M | <0.1% | Unchanged |
| VERA Vera Therapeutics, Inc. | 241,264 | $6.5M | <0.1% | Unchanged |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2,823,126 | $5.3M | <0.1% | Unchanged |
| SANA Sana Biotechnology, Inc. | 2,812,500 | $4.9M | <0.1% | Unchanged |
| LYEL Lyell Immunopharma, Inc. | 293,256 | $4.0M | <0.1% | Unchanged |
| FIG Figma, Inc. | 215,582 | $3.5M | <0.1% | Unchanged |
| GLUE Monte Rosa Therapeutics, Inc. | 372,474 | $3.3M | <0.1% | Unchanged |
| HYPR Hyperfine, Inc. | 898,720 | $471K | <0.1% | Unchanged |